Champions Oncology (CSBR) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.96 -4.25%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $16.6 million versus the consensus estimate of $16.43 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
